Documentos de Académico
Documentos de Profesional
Documentos de Cultura
est
2, CZ-16206 Prague, Czech Republic
Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovskeho
nam
3
rska 2, CZ-61137 Brno, Czech Republic
Department of Theoretical and Physical Chemistry, Faculty of Science, Masaryk University, Kotla
4
ter
8, H-6720 Szeged, Hungary
Department of Medicinal Chemistry, University of Szeged, Dom
5
est
2, CZ-16610 Prague, Czech
Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nam
Republic
The 15 N NMR chemical shifts of N7 - and N9 -substituted purine derivatives were investigated systematically
at the natural abundance level of the 15 N isotope. The NMR chemical shifts were determined and assigned
using GSQMBC, GHMBC, GHMQC and GHSQC experiments in solution. 15 N cross-polarization magic
angle spinning data were recorded for selected compounds in order to study the principal values of the 15 N
chemical shifts. Geometric parameters obtained by using RHF/631G and single-crystal x-ray structural
analysis were used to calculate the chemical-shielding constants (GIAO and IGLO) which were then used
to assign the nitrogen resonances observed in the solid-state NMR spectra and to determine the orientation
of the principal components of the shift tensors. Copyright 2002 John Wiley & Sons, Ltd.
KEYWORDS: NMR; 1 H NMR; 15 N NMR; isotropic chemical shifts; shift tensor; regio-isomerism; purine; quantum-chemical
calculation
INTRODUCTION
N9 -substituted analogs of natural purine nucleosides have
been extensively investigated for their biological activity,
especially as anticancer and antiviral compounds.1 3 N7 nucleoside analogs have been studied less frequently,4 7
often in context with N7 /N9 -glycosyl transfer.8 The standard method of choice for preparing N9 -alkyladenines is
the alkylation of the nucleobase in the presence of a base.
The regioselectivity of this alkylation depends on the reaction conditions and on the nature of the purine base (e.g.
substitution, protective groups, aza and deaza analogs). In
most cases, the N7 -regioisomer9 12 or N3 -regioisomer13,14
is obtained as a side product of the N9 -alkylation reaction. Predicting the site of alkylation is very difficult
when protected or modified adenine is used. For example, we recently found that the alkylation of N6 -[(N,Ndimethylamino)methylene]adenine with certain alkylating
reagents leads selectively to the N7 -substituted derivatives.15
Alkylation of 2-aza- and 8-azaadenine produced the N2 and N8 -substituted side products, respectively.16,17 In addition to standard 1 H and 13 C NMR techniques, 1 H 15 N
Correspondence
354
R. Marek et al.
11
O
1
Ibu
10
N9
N3
NH
N-1
N-3
N-7
N-9
N-10
N-12
1
2
3
4
5a
5b
5c
6ae
6be
7ae
7be
8
152.4
153.5
c
238.8
235.6
235.5
235.5
248.3
249.1
252.2
252.8
236.7
201.1
182.8
180.0
242.4
221.8
221.9
222.2
256.4
256.5
234.3
234.6
224.8
165.6
249.2
173.7
144.2
239.4
239.1
238.7
141.1
138.9
246.6
247.4
240.9
250.5
156.6
161.4
246.2
153.6
154.5
155.6
248.7
249.8
146.2
145.2
152.7
137.1
137.4
139.2
141.6
142.1
142.2
142.1
202.1
202.1
211.2
211.4
81.6
121.3d
120.9d
120.9d
c
107.2 253.1
106.6
105.2 253.2
105.0
Ibu
N7
N
NH
10
11
HN
N9
3
11
N-17
Ph
HN
Compound
HN
Br
Ibu NH
N9
N3
10
COOtBu
COOtBu
12
Ibu = isobutyryl
Ph2N
12
11
O
1
Ibu
12
NH
10
COOMe
1
N7
N
N
Ibu
NH
10
11
11
R
N7
N3
N9
6a: R=CN17
6b: R=CF3
N9
3
10
N(Me)2
10
COOR
5a: R=Me
5b: R=tBu
5c: R=H
12
N(Me)2
11
12
NPh2
N 10
1N
NH2
7a: R=CN17
7b: R=CF3
N9
12
11
N9
3
N2
O
Scheme 1
15 N
Ph-H
H-8
H-11
H-10
ppm
120
140
160
N-12
N-10
imp.
N-9
180
200
220
240
N-3
N-1
N-7
11.0 10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5
ppm
N-9
N-7
N-10
Compound 4
260
240
N-7
220
200
180
N-12
160
N-1 N-3
N-9
140
240
220
200
180
160
ppm
N-10
Compound 5a
260
120
N-12
140
120
ppm
15 N
355
356
R. Marek et al.
Table 2.
15 N
Compound
CP/MAS NMR dataa (relative to liquid NH3 ) for derivatives 5a, 6b and 7a
Parameter
N-1
N-3
N-7
N-9
N-10
N-12
N-17
5a
iso
11 b
22 b
33 b
c
d
Spane
229.0
421.4
190.5
75.1
288.6
0.60
346.3
220.8
428.0
215.7
18.8
310.8
0.95
409.2
236.4
487.4
211.3
10.5
376.5
0.80
476.9
153.1
242.1
146.4
70.8
133.5
0.85
171.3
144.9
214.1
132.6
87.8
103.9
0.65
126.3
119.8
f
f
f
f
f
f
6b
iso
11 b
22 b
33 b
c
d
Spane
248.5
448.0
317.6
19.9
299.2
1.69
467.9
255.5
462.5
321.7
16.0
309.7
1.63
478.5
141.4
238.0
104.1
83.9
144.0
0.21
154.1
251.1
425.6
308.0
26.7
258.2
1.61
398.9
204.5
369.2
234.4
3.6
250.2
1.40
365.6
107.2
204.1
63.1
55.8
144.6
0.08
148.3
7a
iso
11 b
22 b
33 b
c
d
Spane
261.0
457.4
347.5
13.1
290.2
1.84
470.5
233.0
449.0
273.0
20.1
322.6
1.36
469.1
244.3
450.3
273.7
12.2
307.4
1.27
438.1
147.1
f
f
f
f
f
f
216.3
401.4
215.4
36.4
275.5
0.97
365.0
112.0
f
f
f
f
f
f
257.1
398.8
398.8
23.6
211.2
2.98
422.4
The isotropic chemical shifts and principal values of shift tensors (ppm) summarized in this table were determined as the average
values from two independent 15 N CP/MAS NMR experiments measured at different spinning frequencies. The isotropic chemical
shift was determined with an experimental error of 0.1 ppm; the experimental error in the determination of the principal values of
the chemical shift oscillates in the range from 0.7 to 5.8 ppm.
b
11 , 22 and 33 (ppm) represent the three components of the shift tensor expressed in its principal axis system with the following rule:
11 22 33 .
c
Anisotropy parameter D 11 22 C 33 /2 (ppm).
d
Asymmetry parameter D j22 33 j/j11 iso j.
e
Span D 11 33 .
f
Value not determined.
N-9
N-1
N-3
N-12
N-7
N-10
ssb
ssb
ssb
400
350
300
250
200
150
ssb
100
ssb
50
ppm
15 N
7
1
9
3
22
N-1
N-3
N-7
N-9
N-10
N-12
N-17
RMSD
4b
5ab
6ac
6bc
6bd
6be
6bf
7ac
7bc
227.1
235.7
242.1
241.8
238.6
245.4
242.8
241.3
240.9
238.7
221.0
265.4
265.8
265.7
268.2
268.0
227.2
229.0
133.9
257.6
136.1
137.8
136.8
133.9
132.7
253.5
250.7
267.2
143.2
254.2
253.3
252.4
258.6
257.5
144.4
146.0
142.1
130.0
205.5
207.3
210.1
203.0
206.1
213.1
213.6
125.5
125.6
98.7
97.1
99.3
93.9
95.9
102.5
101.2
246.5
256.4
10.9
10.0
6.6
6.7
7.3
8.3
8.1
6.2
5.9
0.4
0.4
18.1
18.1
2.7
14.1
0.7
18.1
18.1
The chemical shifts were calculated as the differences between the shielding constant of a standard
(ammonia D 245.07)44 and the shielding constants of a given molecule: i D 245.07 i . The chemical shifts
were shifted by the constant c. The constant c was found by minimizing the root mean square deviation (RMSD)
between the calculated values and the data observed in solution for all nitrogen atoms.45 The same constant c was
applied for all molecules calculated at the same level.
b
Geometry AM1; shielding B3LYP/631G .
c
Geometry RHF/631G ; shielding B3LYP/631G .
d
Geometry RHF/631G ; shielding IGLO II.
e
Geometry x-ray; shielding B3LYP/631G .
f
Geometry x-ray; shielding IGLO II.
357
358
R. Marek et al.
Table 4. Ab initio calculateda values of the 15 N chemical shifts (ppm) for compounds 57
Compound
Parameter
N-1
N-3
N-7
N-9
N-10
N-12
N-17
5ac
iso
11
22
33
Spanb
235.7
401.1
290.4
15.7
385.4
221.0
390.9
268.8
3.1
387.8
257.6
482.6
297.0
6.9
489.5
143.2
219.2
121.2
79.3
139.9
130.0
232.5
97.5
60.1
172.4
125.6
189.3
98.2
89.3
100.0
6ad
iso
11
22
33
Spanb
242.1
434.8
326.3
8.1
442.9
265.4
484.7
343.0
4.4
489.1
136.1
221.5
118.9
95.1
126.4
254.2
449.6
307.5
32.6
417.0
205.5
365.8
251.2
26.3
339.5
98.7
188.6
76.2
58.5
130.1
246.5
403.5
396.9
33.8
437.3
6bd
iso
11
22
33
Spanb
241.8
423.8
317.5
16.0
439.8
265.8
476.2
334.7
13.5
489.7
137.8
214.1
114.8
84.4
129.7
253.3
438.5
399.4
21.8
416.7
207.3
363.1
243.1
15.8
347.3
97.1
176.3
67.7
47.3
129.0
7ad
iso
11
22
33
Spanb
241.3
416.4
322.0
14.4
430.8
227.2
398.3
309.1
25.8
424.1
253.5
465.6
296.8
2.0
467.6
144.4
214.3
125.9
92.9
121.4
213.1
381.3
244.5
13.4
367.9
102.5
180.7
67.4
59.4
121.3
256.4
404.7
403.1
38.6
443.3
7bd
iso
11
22
33
Spanb
240.9
424.3
330.6
5.3
429.6
229.0
410.8
319.6
16.6
427.4
250.7
468.4
303.0
7.5
460.9
146.0
224.1
141.7
99.3
124.8
213.6
391.6
253.4
22.8
368.8
101.2
187.5
76.6
66.3
121.2
The chemical shifts were calculated analogously to the procedure described in footnote a to Table 3 (geometry RHF/631G ;
shielding B3LYP/631G ) with the exception of compound 5a (geometry AM1; shielding B3LYP/631G ). The constant c was
obtained as described in footnote a to Table 3.
b
Span D 11 33 .
c
c D 0.4.
d
c D 18.1.
EXPERIMENTAL
Purine derivatives 18 were prepared according to the
procedures described in the literature.15,21,46
All solution-phase NMR spectra were recorded using
a Bruker Avance DRX 500 spectrometer operating at
frequencies of 500.13 MHz (1 H) and 50.68 MHz (15 N). The
temperature of the measurements was 303 K. Samples were
prepared by dissolving 50 mg of the purine in 550 l
of DMSO-d6 . The 15 N resonances were referenced to the
signal of 1 M urea in DMSO-d6 (77.0 ppm) and liquid
CH3 NO2 (4 mm coaxial tube in a 5 mm tube with DMSOd6 ) (381.7 ppm).37 The pulse conditions were 90 pulse,
duration 8.29.0 s for 1 H, 20.5 s for 15 N (5 mm tripleresonance inverse probehead f1 H/BB/13 Cg equipped with
a self-shielded z-gradient coil). Computer processing was
performed with Bruker XWINNMR software.
GHSQC and GSQMBC spectra were measured in the
phase-sensitive mode (processed using the echoantiecho
protocol47 49 ) and with magnetic field gradients. GHMQC
and GHMBC spectra were processed in the magnitude mode.
A gradient pulse duration of 1 ms and a post-gradient
recovery delay of 100 s were used. The gradient ratios
were 4.8 : 52.8 : 4.8 G cm1 for the 1 H 15 N GHSQC and
GSQMBC experiments and 42 : 18 : 30 G cm1 for the 1 H 15 N
GHMQC and GHMBC experiments. The delay for evolution
of single- and multiple-bond couplings was set to 5.5 and
120140 ms, respectively (with 232 transients accumulated
per t1 increment). Directly detected 15 N NMR spectra were
observed for samples prepared by dissolving 300 mg of the
purine in 2.5 ml of DMSO-d6 and using a BBO probehead
(10 mm diameter) with a 15 s 15 N pulse.
The 15 N CP/MAS NMR spectra of solid samples were
measured using a Bruker DSX 200 NMR spectrometer at
a frequency of 20.28 and 200.14 MHz for 15 N and 1 H,
15 N
Acknowledgments
This work was supported by grants from the Ministry of Education
of the Czech Republic (LN00A016) (R.M.), the Grant Agency of the
Czech Republic (203/98/P026) (D.H.) and the Hungarian National
Scientific Research Fund (OTKA) (T 22551) (L.K.). We express our
gratitude to the staff members of the supercomputing centers in
Brno and Prague for CPU time.
REFERENCES
1. Huryn DM, Okabe M. Chem. Rev. 1992; 92: 1745.
2. Holy A. In Advances in Antiviral Drug Design, vol. 1, De Clerq E
(ed.). JAI Press: Greenwich, CT, 1993; 179232.
3. Holy A, Dvora kova H, Jindrich J. In Antibiotics and Antiviral
Compounds, Krohn K, Kirst HA, Maag H (eds). VCH: Weinheim,
1993; 455462.
33. Bodenhausen G, Ruben DJ. Chem. Phys. Lett. 1980; 69: 185.
34. Willker W, Leibfritz D, Kerssebaum R, Bermel W. Magn. Reson.
Chem. 1993; 31: 287.
35. Bax A, Summers MF. J. Am. Chem. Soc. 1986; 108: 2093.
36. Marek R, Kralk L, Sklenar V. Tetrahedron Lett. 1997; 38: 665.
37. Wishart DS, Bigam CG, Yao J, Abildgaard F, Dyson HJ,
Oldfield E, Markley JL, Sykes BD. J. Biomol. NMR 1995; 6: 135.
38. Witanowski M, Stefaniak L, Webb GA. Annu. Rep. NMR
Spectrosc. 1993; 25: 1.
39. Marek R, Humpa O, Dostal J, Slavk J, Sklenar V. Magn. Reson.
Chem. 1999; 37: 195.
40. Solum MS, Altmann KL, Strohmeier M, Berges DA, Zhang Y,
Facelli JC, Pugmire RJ, Grant DM. J. Am. Chem. Soc. 1997; 119:
9804.
41. Ditchfield R. Mol. Phys. 1974; 27: 789.
42. Kutzelnigg W. Isr. J. Chem. 1980; 19: 193.
43. Kutzelnigg W, Fleischer U, Schindler M. In NMRBasic
Principles and Progress, vol. 23, Diehl P, Fluck E, Gunther
H,
359
360
R. Marek et al.
47. Davis AL, Keeler J, Laue ED, Moskau D. J. Magn. Reson. 1992; 98:
207.
48. Tolman JR, Chung J, Prestegard J. J. Magn. Reson. 1992; 98: 462.
49. Boyd J, Soffe N, John BK, Plant D, Hurd RE. J. Magn. Reson. 1992;
98: 660.
50. Frisch MJ, Trucks GW, Schlegel HB, Gill PMW, Johnson BG,
Robb MA, Cheeseman JR, Keith T, Petersson GA, Montgomery
JA, Raghavachari K, Al-Laham MA, Zakrzewski VG, Ortiz JV,